# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-111484
Filing Date
2025-11-13
Accepted
2025-11-13 17:13:40
Documents
138
Period of Report
2025-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | chrs-20251113x8k.htm iXBRL | 8-K | 264820
2 | EX-23.1 | chrs-20251113xex23d1.htm | EX-23.1 | 9040
3 | EX-99.1 | chrs-20251113xex99d1.htm iXBRL | EX-99.1 | 2423604
| Complete submission text file | 0001104659-25-111484.txt |  | 16454992

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | EX-101.SCH | chrs-20251113.xsd | EX-101.SCH | 135842
5 | EX-101.CAL | chrs-20251113_cal.xml | EX-101.CAL | 148527
6 | EX-101.DEF | chrs-20251113_def.xml | EX-101.DEF | 620874
7 | EX-101.LAB | chrs-20251113_lab.xml | EX-101.LAB | 1064740
8 | EX-101.PRE | chrs-20251113_pre.xml | EX-101.PRE | 962532
141 | EXTRACTED XBRL INSTANCE DOCUMENT | chrs-20251113x8k_htm.xml | XML | 3238738

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251479737
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)